Search Results

Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics

competitive edge:  Learn to leverage restricted diffusion and rebinding to create drugs with longer therapeutic

GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet

Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic

modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic

GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus.

Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024 Domain Therapeutics

accurately reflect native biological processes and preclinical research can more reliably translate into therapeutic Trends in clinical success rates and therapeutic focus. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief

Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation

MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic

Essential Frameworks for Precision Drug Discovery: An Insight into Advanced Strategies for Targeted Therapeutics

GPCR dimers are therefore emerging drug targets in different therapeutic areas including depression,

GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics

20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic

and triterpenes isolated from Cryptostegia grandiflora against Candida auris FKBP12 Development and therapeutic

Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics

Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024.

continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic

Industry News Monash University retains its N° 2 global ranking for Pharmacy and Pharmacology Addex Therapeutics

GPCR Binders, Drugs, and more Advances in structure-based drug design: The potential for precision therapeutics

GPCRs in Neuroscience CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8

crystal structures of both CBRs.[4–8] A key challenge in CBR modulator development is separating the therapeutic New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.

have been approved as drugs, however they often have serious side effects and too low or temporary therapeutic Pharmacology & Therapeutics   2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007

This scavenging function should be considered when evaluating the safety and therapeutic efficacy of

within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic

binding and receptor activation will pave the way for significant advancements in the development of therapeutics